Public filings / DMRA on Yahoo Finance (opens in a new tab)
DMRA: insider buying, 13F holders, analyst moves
Damora Therapeutics Inc
A summary of public filings about Damora Therapeutics Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold DMRA
Combined reported value $252.7M.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $98.4M | 0.88% | Unchanged |
| RA Capital | $62.4M | 0.54% | Unchanged |
| Viking Global Investors | $60.1M | 0.17% | Unchanged |
| Perceptive Advisors | $31.8M | 0.49% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.